COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,741 Articles (22,502 medRxiv, 8,239 bioRxiv)

Most recent first Previous |  Page 3019: Articles 30181-30190  | Next

Impact of self-imposed prevention measures and short-term government intervention on mitigating and delaying a COVID-19 epidemic
Teslya, A., Pham, T. M., Godijk, N. E., Kretzschmar, M. E., Bootsma, M. C. J., Rozhnova, G.
10.1101/2020.03.12.20034827 — Posted: 2020-03-16
Rational evaluation of various epidemic models based on the COVID-19 data of China
Yang, W., Zhang, D., Peng, L., Zhuge, C., Hong, L.
10.1101/2020.03.12.20034595 — Posted: 2020-03-16
Impact assessment of non-pharmaceutical interventions against COVID-19 and influenza in Hong Kong: an observational study
Cowling, B. J., Ali, S. T., Ng, T. W. Y., Tsang, T. K., Li, J. C. M., Fong, M. W., Liao, Q., Kwan, M. Y., Lee, S. L., Chiu, S. S., Wu, J. T., Wu, P., Leung, G. M.
10.1101/2020.03.12.20034660 — Posted: 2020-03-16
Evaluating the effect of public health intervention on the global-wide spread trajectory of Covid-19
Hu, Z., Ge, Q., Li, S., Jin, L., Xiong, M.
10.1101/2020.03.11.20033639 — Posted: 2020-03-16
Estimation of the final size of the second phase of the coronavirus epidemic by the logistic model
batista, m.
10.1101/2020.03.11.20024901 — Posted: 2020-03-16
Relationship between the ABO Blood Group and the COVID-19 Susceptibility
Zhao, J., Yang, Y., Huang, H.-P., Li, D., Gu, D.-F., Lu, X.-F., Zhang, Z., Liu, L., Liu, T., Liu, Y.-K., He, Y.-J., Sun, B., Wei, M.-L., Yang, G.-Y., Wang, X., Zhang, L., Zhou, X.-Y., Xing, M.-Z., Wang, P. G.
10.1101/2020.03.11.20031096 — Posted: 2020-03-16 Discussion: Onsite | Offsite
A Method to Model Outbreaks of New Infectious Diseases with Pandemic Potential such as COVID-19
Odendaal, W. G.
10.1101/2020.03.11.20034512 — Posted: 2020-03-16
Environmental contamination of the SARS-CoV-2 in healthcare premises: An urgent call for protection for healthcare workers
Ye, G., Lin, H., Chen, L., Wang, S., Zeng, Z., Wang, W., Zhang, S., Rebmann, T., Li, Y., Pan, Z., Yang, Z., Wang, Y., Wang, F., Qian, Z., Wang, X.
10.1101/2020.03.11.20034546 — Posted: 2020-03-16
Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China
Shi, Y., Tan, M., Chen, X., Liu, Y., Huang, J., Ou, J., Deng, X.
10.1101/2020.03.12.20034736 — Posted: 2020-03-16 Discussion: Onsite
Generalized logistic growth modeling of the COVID-19 outbreak in 29 provinces in China and in the rest of the world
Wu, K., Darcet, D., Wang, Q., Sornette, D.
10.1101/2020.03.11.20034363 — Posted: 2020-03-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).